Editorial: Vaccines, immunotherapy and new antifungal therapy against fungi: Updates in the new frontier

Carlos P. Taborda; Joshua D. Nosanchuk

doi:10.3389/fmicb.2017.01743

Editorial: Vaccines, immunotherapy and new antifungal therapy against fungi: Updates in the new frontier

Carlos P. Taborda
, Joshua D. Nosanchuk

Medicine

Research output: Contribution to journal › Editorial › peer-review

12 Scopus citations

Original language	English (US)
Article number	1743
Journal	Frontiers in Microbiology
Volume	8
Issue number	SEP
DOIs	https://doi.org/10.3389/fmicb.2017.01743
State	Published - Sep 8 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antifungal agents
Editorial
Fungi
Immunotherapy
Vaccines

ASJC Scopus subject areas

Microbiology
Microbiology (medical)

Access to Document

10.3389/fmicb.2017.01743

Cite this

@article{9f04f52862e94ac4a615ee41080f6b9b,

title = "Editorial: Vaccines, immunotherapy and new antifungal therapy against fungi: Updates in the new frontier",

keywords = "Antifungal agents, Editorial, Fungi, Immunotherapy, Vaccines",

author = "Taborda, \{Carlos P.\} and Nosanchuk, \{Joshua D.\}",

note = "Funding Information: The authors sincerely acknowledge the efforts of all of the authors who contributed to this Research Topic. JN is supported in part by NIH AI52733 and AI124797. CT is supported by grants 2016/08730-6 from Funda{\c c}{\~a}o de Amparo {\`a} Pesquisa do Estado de S{\~a}o Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico (CNPq).",

year = "2017",

month = sep,

day = "8",

doi = "10.3389/fmicb.2017.01743",

language = "English (US)",

volume = "8",

journal = "Frontiers in Microbiology",

issn = "1664-302X",

publisher = "Frontiers Media SA",

number = "SEP",

}

TY - JOUR

T1 - Editorial

T2 - Vaccines, immunotherapy and new antifungal therapy against fungi: Updates in the new frontier

AU - Taborda, Carlos P.

AU - Nosanchuk, Joshua D.

N1 - Funding Information: The authors sincerely acknowledge the efforts of all of the authors who contributed to this Research Topic. JN is supported in part by NIH AI52733 and AI124797. CT is supported by grants 2016/08730-6 from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

PY - 2017/9/8

Y1 - 2017/9/8

KW - Antifungal agents

KW - Editorial

KW - Fungi

KW - Immunotherapy

KW - Vaccines

UR - https://www.scopus.com/pages/publications/85029222844

UR - https://www.scopus.com/pages/publications/85029222844#tab=citedBy

U2 - 10.3389/fmicb.2017.01743

DO - 10.3389/fmicb.2017.01743

M3 - Editorial

AN - SCOPUS:85029222844

SN - 1664-302X

VL - 8

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

IS - SEP

M1 - 1743

ER -

Editorial: Vaccines, immunotherapy and new antifungal therapy against fungi: Updates in the new frontier

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this